4
Changes in Ownership
Cogent Biosciences, Inc. Filed Acc 0001209191-19-002037
Options or other derivatives
- Director acquired 4,999 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Aldag Jorn Director | 2019-01-02 | Grant or award · Stock Option (Right to Buy) | +4,999 | $2.70 | $13,497 | 4,999 | D |
Loading xslF345X03/doc4.xml…